The Novel Coronavirus Response and Coordination Centre announced in a statement last night that a 33-year-old man who received his first Sinopharm inactivated jab last month has been diagnosed with Bell’s palsy (a type of facial paralysis).
Yesterday’s statement pointed out that it is the ninth Bell’s palsy case following a COVID-19 vaccination reported in Macau.
The man, according to statement, was diagnosed with Bell’s palsy on Tuesday after seeking treatment at the emergency department of the private Kiang Wu Hospital, when he received outpatient treatment.
According to the statement, the man received his first Sinopharm jab on June 18.
Kiang Wu Hospital reported the case to the Health Bureau (SSM) yesterday.
Yesterday’s statement did not mention whether the case has been classified as a minor or serious post-vaccination adverse event, merely saying that it has been classified as a “post-vaccination adverse event of concern”.
The case will be transferred to the Health Bureau’s special working group tasked with assessing serious adverse events after COVID-19 vaccinations.
In addition to serious cases, the working group also assesses “post-COVID-19 vaccination adverse events of concern”.
Meanwhile, the centre announced in another statement yesterday that as of 4 p.m. yesterday, 387,925 doses of COVID-19 vaccine had been administered to 254,109 people in Macau, comprising 118,774 who had received their first jab and 135,335 who had received their second jab.
A total of 37 adverse events were reported in the past 24 hours (until 4 p.m. yesterday). The total number of adverse events since the start of the vaccination drive stood at 1,696, or 0.44 percent of the total number of jabs, including five serious cases.
